title: Trial of risperidone in India--concerns.
authors.forename: S
authors.initials: S
authors.lastname: Srinivasan
authors.forename: S A
authors.initials: SA
authors.lastname: Pai
authors.forename: A
authors.initials: A
authors.lastname: Bhan
authors.forename: A
authors.initials: A
authors.lastname: Jesani
authors.forename: G
authors.initials: G
authors.lastname: Thomas
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use; D001291:Attitude of Health Personnel; D001714:Bipolar Disorder / Q000188:drug therapy; D002986:Clinical Trials as Topic / Q000941:ethics*; D026690:Ethics, Clinical; D006381:Helsinki Declaration; D006801:Humans; D007194:India; D010919:Placebos / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D018967:Risperidone / Q000627:therapeutic use
chemical_list: D014150:Antipsychotic Agents; D010919:Placebos; D018967:Risperidone